Last updated:
Author(s):
Jure Mur, Tom C. Russ, Simon R. Cox, Riccardo E. Marioni, Graciela Muniz-Terrera
Publish date:
1 January 2022
Journal:
Alzheimer's & Dementia: Translational Research & Clinical Interventions
PubMed ID:
35434252

Abstract

Background: Previous studies on the relationship between anticholinergic drugs and dementia have reported heterogeneous results. This variability could be due to different anticholinergic scales and differential effects of distinct classes of drugs.

Methods: Using Cox proportional hazards models, we computed the association between annual anticholinergic burden (AChB) and the risk of dementia in UK Biobank with linked general practitioner prescription records between the years 2000 and 2015 (n = 171,775).

Results: AChB according to most anticholinergic scales (standardized odds ratio range: 1.027-1.125) and the slope of the AChB trajectory (hazard ratio = 1.094; 95% confidence interval: 1.068-1.119) were predictive of dementia. However, the association between AChB and dementia held only for some classes of drugs, especially antidepressants, antiepileptics, and antidiuretics.

Discussion: The heterogeneity in previous findings may partially be due to different effects for different classes of drugs. Future studies should establish differences in more detail and further examine the practicality of a general measure of AChB relating to the risk of dementia.

Related projects

The proposed research aims to understand why it is that poorer cognitive function and negative emotional factors are typically associated with poorer health and increased…

Institution:
University of Edinburgh, Great Britain

All projects